Effect of Intravenous Streptokinase on Acute Myocardial Infarction
New England Journal of MedicinePublished 4 November 1982
Meir J. Stampfer, Samuel Z. Goldhaber, Salim Yusuf, Richard Peto, Charles H. Hennekens
Citations208
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Intracoronary infusion of streptokinase in patients with acute myocardial infarction is an exciting and innovative technique for reperfusion of the ischemic myocardium, but its net benefits have not yet been reliably estimated.
Abstract
Intracoronary infusion of streptokinase in patients with acute myocardial infarction is an exciting and innovative technique for reperfusion of the ischemic myocardium,1 2 3 4 but its net benefits have not yet been reliably estimated.Intravenous infusion of streptokinase is less invasive, less expensive, and easier than intracoronary infusion, and its effects have already been studied in randomized trials. Inevitably, when several trials address the same or a similar question, they are unlikely to yield identical results, and in these circumstances an overview of the results of all the strictly randomized trials can be useful.5 6 7 Although the play of chance may well produce . . .
Keywords
Medicine
New England Journal of MedicineThe Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control Trial
1,641 Citations1978Jennie A. Freiman, Thomas C. Chalmers +2 more
American Journal of EpidemiologyRE: “ESTIMABILITY AND ESTIMATION IN CASE-REFERENT STUDIES”
1,557 Citations1977Max Halperin
American Journal of EpidemiologyESTIMABILITY AND ESTIMATION IN CASE-REFERENT STUDIES
1,325 Citations1976Olli S. Miettinen
The concepts that case-referent studies provide for the estimation of "relative risk" only if the illness is "rare", and that the rates and risks themselves are inestimable, are overly superficial and restrictve.
Clinical CardiologyAcute myocardial infarction: Intracoronary application of nitroglycerin and streptokinase
414 Citations1979K.Peter Rentrop, H. Blanke +5 more
The findings suggest that myocardial infarction had been caused by thrombotic occlusion in four patients, and that spasm of the infarct vessel could have been an additional factor in two of these patients.
Annals of Internal MedicineAnticoagulants and Myocardial Infarction
127 Citations1979Lee Goldman, Alvan R. Feinstein
Clinically, even when the pooling process is appropriate, recent changes in ancillary therapy may negate the applicability of the old data to current medical practice.
BMJStreptokinase in Recent Myocardial Infarction: A Controlled Multicentre Trial
108 Citations1971European Working Party
It is indicated that in recent myocardial infarction streptokinase was superior to heparin in reducing mortality and reinfarction rate during an average period of six weeks in hospital.
BMJStreptokinase in acute myocardial infarction: a controlled multicentre study in the United Kingdom.
98 Citations1976C. P. Aber, N. M. Bass +12 more
An infusion of streptokinase within 24 hours of the onset of acute myocardial infarction does not significantly affect the mortality or course of the illness up to six months, and there was no significant difference in the peak levels or pattern of enzyme increase.
The LancetLIGNOCAINE PROPHYLAXIS IN ACUTE MYOCARDIAL INFARCTION: AN EVALUATION OF RANDOMISED TRIALS
97 Citations1981RegisA. Desilva, BernardJ Own +4 more
It is concluded that lignocaine treatment provides prophylaxis against VF in acute MI and the failure of most trials to demonstrate such an effect is due to small sample sizes and inadequate treatment protocols.
The LancetCONTROLLED TRIAL OF STREPTOKINASE AND HEPARIN IN ACUTE MYOCARDIAL INFARCTION
85 Citations1971N Dioguardi, A Lotto +9 more
Results do not suggest that streptokinase therapy would reduce the morbidity and the mortality in patients with acute myocardial infarction treated in coronary-care units with the dosage and selection of cases used in this trial.
The LancetAUSTRALIAN MULTICENTRE TRIAL OF STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION
84 Citations1973J. H. N. Bett, P.A. Castaldi +10 more
The Australian multicentre trial of streptokinase in acute myocardial infarction has now been concluded and there was no significant difference in mortality.
American Journal of Public Health and the Nations HealthCombination of log relative risk in retrospective studies of disease.
75 Citations1966Paul R. Sheehe
The combination of estimates of relative prevalence or incidence, commonly referred to as relative risk, obtained from retrospective 2 X 2 tables, is discussed, involving the iterative solution of sets of quadratic equations.
Acta Medica ScandinavicaFIBRINOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION
70 Citations1971R Heikinheimo, P. Ahrenberg +8 more
The present study did not support the view that streptokinase (SK) would be beneficial in the treatment of myocardial infarction.
Annals of Internal MedicineClinical Trials of Thrombolytic Agents in Myocardial Infarction
65 Citations1973Toby L. Simon, JAMES H. WARE +1 more
Two new thrombolytic agents, such as streptokinase and urokinase, rapidly dissolve arterial thrombi and have shown the potential to reduce mortality from acute thrombotic events.
DMW - Deutsche Medizinische WochenschriftDie Kurzzeitfibrinolyse beim akuten Myokardinfarkt
64 Citations1973K. Breddin, A. M. Ehrly +15 more
New England Journal of MedicineLet's Not Let the Genie Escape from the Bottle — Again
49 Citations1981James E. Muller, Peter H. Stone +2 more
If optimum care is to be provided to the million or so patients who have acute myocardial infarction each year, this technique deserves more carefully designed evaluation than that given a similarly bold and exciting technique developed a little more than a decade ago: coronary-artery bypass grafting.
The American Journal of MedicineCoronary thrombolysis: Some unresolved issues
36 Citations1982Burton E. Sobel, Steven R. Bergmann
Salvage of jeopardized myocardium is predicated on the evolutionary nature of infarction, its dependence on the balance between oxygen supply and demand and its influence on prognosis, and the timing of potentially therapeutic interventions is critical, since prolonged ischemia precludes survival of myocardia.
Journal of Internal MedicineBIOCHEMICAL EVALUATION OF STANDARD TREATMENT WITH STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION
22 Citations1972Johs. Gormsen
The study showed that a standard treatment can be performed without difficulties or serious complications, producing significant fibrinolytic activity in around 80–90% of the patients.